# Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy

> **NCT00784212** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 13 (actual)

## Conditions studied

- Photosensitive Epilepsy

## Interventions

- **DRUG:** BGG492
- **DRUG:** BGG492
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00784212
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2016-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00784212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00784212, "Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00784212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*